Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.
暂无分享,去创建一个
Ming You | M. You | A. McDoniels-Silvers | R. Lubet | G. Stoner | C. Nimri | Gary D Stoner | Ronald A Lubet | Amy L McDoniels-Silvers | Caramella F Nimri
[1] R. Beijersbergen,et al. Cloning, expression and chromosomal localization of a new putative receptor‐like protein tyrosine phosphatase , 1991, FEBS letters.
[2] J. Roman,et al. Fibronectin and fibronectin receptors in lung development. , 1997, Experimental lung research.
[3] M. Borrello,et al. Multiple molecular alterations in mouse lung tumors , 1992, Molecular carcinogenesis.
[4] Molecular pathogenesis of lung cancer. , 1999, The Journal of thoracic and cardiovascular surgery.
[5] N. Nagy,et al. Human ex vivo carcinoma cells produce transforming growth factor β and thereby can inhibit lymphocyte functions in vitro , 1997, Cancer Immunology, Immunotherapy.
[6] S. Spivack,et al. The molecular epidemiology of lung cancer. , 1997, Critical reviews in toxicology.
[7] J. Yokota,et al. Identification of genes (SPON2 and C20orf2) differentially expressed between cancerous and noncancerous lung cells by mRNA differential display. , 1999, Genomics.
[8] J. Yokota,et al. How many tumor suppressor genes are involved in human lung carcinogenesis? , 1999, Carcinogenesis.
[9] L. Isaac,et al. Murine alpha-2-macroglobulin increase during inflammatory responses and tumor growth , 1999, Inflammation Research.
[10] H. Hameister,et al. Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells , 1999, Oncogene.
[11] M. You,et al. Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitor , 2001, Oncogene.
[12] H. Sorimachi,et al. A Novel Ligand for CD44 Is Serglycin, a Hematopoietic Cell Lineage-specific Proteoglycan , 1995, The Journal of Biological Chemistry.
[13] A. Bretscher,et al. cDNA cloning and sequencing of the protein‐tyrosine kinase substrate, ezrin, reveals homology to band 4.1. , 1989, The EMBO journal.
[14] Ruo-Pan Huang,et al. The Transcription Factor EGR-1 Suppresses Transformation of Human Fibrosarcoma HT1080 Cells by Coordinated Induction of Transforming Growth Factor-β1, Fibronectin, and Plasminogen Activator Inhibitor-1* , 1999, The Journal of Biological Chemistry.
[15] P. Mangeat,et al. ERM proteins in cell adhesion and membrane dynamics. , 1999, Trends in cell biology.
[16] W. J. Brammar,et al. Differential expression of the mitochondrial gene cytochrome oxidase ii in benign and malignant breast tissue , 1992, The Journal of pathology.
[17] P. Comoglio,et al. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas. , 1996, British Journal of Cancer.
[18] P. Newman. Switched at birth: a new family for PECAM-1. , 1999, The Journal of clinical investigation.
[19] A. Barrett,et al. The interaction of α2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism , 1973 .
[20] M. Fellous,et al. Presence of an abnormal β2-microglobulin mRNA in Daudi cells: Induction by interferon , 2004, Immunogenetics.
[21] Dietel,et al. Thyroid transcription factor‐1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B , 2000, Histopathology.
[22] R. Hynes,et al. Cell surface fibronectin and oncogenic transformation. , 1979, Journal of supramolecular structure.
[23] S. Galli,et al. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-Kit by the protein tyrosine phosphatase SHP1 , 1996, The Journal of experimental medicine.
[24] R. Figlin,et al. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. , 1995, Oncogene.
[25] Johnson Be,et al. The biology of lung cancer. , 1993, Seminars in oncology.
[26] G. Nicolson,et al. Transcripts of the mitochondrial gene ND5 are overexpressed in highly metastatic murine large cell lymphoma cells. , 1992, In vivo.
[27] D. Mercola,et al. Transcription factor EGR-1 suppresses the growth and transformation of human HT-1080 fibrosarcoma cells by induction of transforming growth factor beta 1. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] M. Reiss,et al. A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression. , 1996, Cancer research.
[29] P. Schraml,et al. Identification of genes differentially expressed in normal lung and non-small cell lung carcinoma tissue. , 1994, Cancer research.
[30] Kakinuma,et al. Expression of fibrogenic cytokines in desmoplastic malignant melanoma , 1998, The British journal of dermatology.
[31] R. Pardi,et al. The platelet endothelial cell adhesion molecule‐1 (PECAM1) contributes to endothelial barrier function , 1995, FEBS letters.
[32] Y. Sibille,et al. Local increase of antiprotease and neutrophil elastase-alpha 1-proteinase inhibitor complexes in lung cancer. , 1989, The European respiratory journal.
[33] A. Mantovani,et al. The origin and function of tumor-associated macrophages. , 1992, Immunology today.
[34] R. Bravo,et al. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. , 1997, Journal of immunology.
[35] W. Bodmer,et al. Beta 2-microglobulin gene mutations: a study of established colorectal cell lines and fresh tumors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] D. Curiel,et al. Surfactant protein A-directed toxin gene kills lung cancer cells in vitro. , 1994, Human gene therapy.
[37] D. Strayer,et al. SP‐A as a cytokine: Surfactant protein‐A–regulated transcription of surfactant proteins and other genes , 1999, Journal of cellular physiology.
[38] N. Mifsud,et al. Expression of Surfactant Protein mRNA in Normal and Neoplastic Lung of B6C3F1 Mice as Demonstrated by In Situ Hybridization , 1999, Veterinary pathology.
[39] S. Tsukita,et al. Occludin and claudins in tight-junction strands: leading or supporting players? , 1999, Trends in cell biology.
[40] C. Garlanda,et al. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. , 1998, Journal of immunology.
[41] J. Jääskeläinen,et al. The ezrin protein family: membrane-cytoskeleton interactions and disease associations. , 1997, Current opinion in cell biology.
[42] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[43] J. Whitsett,et al. Expression of surfactant protein B precursor and surfactant protein B mRNA in adenocarcinoma of the lung. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[44] S. L. Gonias,et al. Alpha 2-macroglobulin: a protein at the interface of fibrinolysis and cellular growth regulation. , 1992, Experimental hematology.
[45] D. Mosher,et al. High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in maglinant transformation , 1978 .
[46] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[47] S. Hedrick. Dawn of the hunt for nonclassical MHC function , 1992, Cell.
[48] R. Ball,et al. IMMUNOREACTIVITY FOR HEPATOCYTE GROWTH FACTOR/SCATTER FACTOR AND ITS RECEPTOR, met, IN HUMAN LUNG CARCINOMAS AND MALIGNANT MESOTHELIOMAS , 1996, The Journal of pathology.
[49] A. Bernstein,et al. Signalling by the W/Kit receptor tyrosine kinase is negatively regulated in vivo by the protein tyrosine phosphatase Shp1 , 1996, Nature Genetics.
[50] A. Vaheri,et al. Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family , 1994, The Journal of cell biology.
[51] D. Rimm,et al. Dynamic Interaction of PTPμ with Multiple Cadherins In Vivo , 1998, The Journal of cell biology.
[52] M. Katabami,et al. Identification of genes that exhibit increased expression after flat reversion of NIH/3T3 cells transformed by human activated Ha-ras oncogene. , 1991, Cancer letters.
[53] G. Peters,et al. The p16INK4a/CDKN2A tumor suppressor and its relatives. , 1998, Biochimica et biophysica acta.
[54] K. Takehara,et al. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors , 1998, Journal of cutaneous pathology.
[55] R. Weinberg,et al. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.
[56] R. Weinberg. Oncogenes and the molecular origins of cancer , 1989 .
[57] G. Krystal,et al. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. , 1996, Cancer research.
[58] A. Pardee,et al. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.
[59] Adriano Fontana,et al. The failure of current immunotherapy for malignant glioma. Tumor-derived TGF-β, T-cell apoptosis, and the immune privilege of the brain , 1995, Brain Research Reviews.
[60] J. Minna,et al. Progress in understanding the molecular pathogenesis of human lung cancer. , 1998, Biochimica et biophysica acta.
[61] D. Bell,et al. Advances in the analysis of chromosome alterations in human lung carcinomas. , 1997, Cancer genetics and cytogenetics.
[62] S. Steinberg,et al. Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets. , 1992, Journal of the National Cancer Institute. Monographs.
[63] J. Deslauriers,et al. Carcinoma of the lung. Evaluation of satellite nodules as a factor influencing prognosis after resection. , 1989, The Journal of thoracic and cardiovascular surgery.
[64] A. Moorman,et al. α2‐Macroglobulin is mainly produced by cancer cells and not by hepatocytes in rats with colon carcinoma metastases in liver , 1996, Hepatology.
[65] T. Matsumura,et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. , 1999, Journal of biochemistry.
[66] M. Weller,et al. Transforming growth factor-β and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth , 1999, Cell and Tissue Research.
[67] T. Tsukamoto,et al. Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. , 1993, Cancer research.
[68] S. Ferrone,et al. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. , 1991, The Journal of clinical investigation.
[69] M. Takigawa,et al. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). , 1998, Biochemical and biophysical research communications.
[70] I. Petersen,et al. Primary small‐cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations , 1997, International journal of cancer.
[71] D. Mercola,et al. Decreased Egr‐1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation , 1997, International journal of cancer.
[72] C. Hack,et al. Apoptosis induced by granzyme B-glycosaminoglycan complexes: implications for granule-mediated apoptosis in vivo. , 1999, Journal of immunology.
[73] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[74] R. Whyte,et al. Expression and activation of erbB-2 and epidermal growth factor receptor in lung adenocarcinomas. , 1995, British Journal of Cancer.